After a preliminary review of the possible opportunities by both companies, both Ortoma and the European Company (previously announced as having an exclusive negotiation period with Ortoma) have mutually agreed to continue exploring possible market commercialization opportunities on a non-exclusive basis. While it's apparent there are market synergies between both companies, initial assessments from our M&A Advisor indicated that both parties may currently lack the global presence required to drive maximum key stakeholder value from a worldwide investment and/or marketing agreement.
Therefore, both Ortoma and its possible future strategic market commercialization collaboration partners (including the European Company previously mentioned) will continue non-exclusive dialogues for the immediate future. This arrangement will allow on-going dialogues between the parties while also providing for Ortoma's M&A Advisor to further assess commercialization and M&A scenarios for both regional and global possibilities for Ortoma.
Ortoma Treatment Solution™ – careful planning and precise surgery.